Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
1.170
+0.040 (3.54%)
Dec 22, 2025, 3:35 PM EST - Market open
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $9.53 million as of December 22, 2025. Its market cap has increased by 135.26% in one year.
Market Cap
9.53M
Enterprise Value
10.34M
1-Year Change
135.26%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $9.53M, a decrease of -97.71%. That is a compound annual growth rate of -41.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 9.20M | -41.40% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | 84.01M | -81.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |